Showing results (401-410 of 430) with videos related to
Sort By:
Pageof 43
CPT: Pharmacometrics & Systems Pharmacology|January 2, 2024
Clofazimine pharmacokinetics in HIV-infected adults with diarrhea: Implications of diarrheal disease on absorption of orally administered therapeuticsCindy X Zhang, Thomas M Conrad, David Hermann, et al.Bone Marrow Transplantation|May 29, 2026
A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastomaSveva Castelli, Tim Flaadt, Franziska Schulze, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with NeuroblastomaMarco Lodrini, Josefine Graef, Theresa M Thole-Kliesch, et al.Frontiers in Immunology|October 27, 2025
From essential basic understanding to clinical application - biological, physical and pathophysiological principles of (low-dose) radiotherapy in benign diseasesLisa Deloch, David Rene Steike, Felix Pascher, et al.Cancer Research|January 15, 2014
GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3Johannes Fabian, Marco Lodrini, Ina Oehme, et al.NPJ Vaccines|February 26, 2026
Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UKEvaristar Kudowa, Godwin Tembo, Anthony E Chirwa, et al.Vaccine|April 3, 2024
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisationG Tembo, M Mayuni, R Kamng'ona, et al.Research Square|April 24, 2023
Utilizing river and wastewater as a SARS-CoV-2 surveillance tool to predict trends and identify variants of concern in settings with limited formal sewage systemsKayla Barnes, Joshua Levy, Kristian Andersen, et al.The Journal of Clinical Investigation|June 8, 2021
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipientsArne Sattler, Eva Schrezenmeier, Ulrike A Weber, et al.Clinical Immunology (Orlando, Fla.)|April 3, 2025
Association of mucosal neutrophil inflammation and cytokine responses with natural and experimental pneumococcal carriage in a randomised vaccine trial using experimental human pneumococcal carriageGift Chiwala, Raphael Kamng'ona, Evaristar Kudowa, et al.Pageof 43